Missing a "Missing Self" Mechanism: Modeling and Detection of Ly49 Expression in Canine NK Cells
Alicia A Gingrich1, Aryana M Razmara1, Phillip W Gingrich2
1Department of Surgery, University of California, Davis School of Medicine, Sacramento, CA.
Abstract:
NK cells are a key focus in immuno-oncology, based on their ability to eliminate malignant cells without prior sensitization. Dogs are valuable models for translational immunotherapy studies, especially for NK cells, where critical species differences exist between mice and humans. Given that the mechanism for recognition of "self" by canine NK cells is currently unknown, we sought to evaluate expression of Ly49 in canine NK cells using in silico and high-throughput techniques. We interrogated the identified polymorphism/mutation in canine Ly49 and assessed the potential impact on structure using computational modeling of three-dimensional protein structure and protein-protein docking of canine Ly49 with MHC class I (MHC-I). Bulk and single-cell RNA-sequencing analysis was performed to detect gene expression of Ly49/KLRA1 in resting and activated NK cells. Tertiary protein structure demonstrated significant structural similarity to the known murine system. Molecular docking of canine Ly49 with MHC-I was favorable, converging at a single low-energy conformation. RNA sequencing revealed expression of Ly49/KLRA1 in both resting and activated NK cells and demonstrated almost exclusive expression of the gene in the NK cluster at the single-cell level. Despite prior reports of a mutated, nonfunctional canine Ly49, our data support that the protein product is predicted to bind to MHC-I in a comparable conformation to the murine system and is expressed in canine NK cells with upregulation following activation. Taken together, these data suggest that Ly49 is capable of recognizing MHC-I and therefore regulating NK cell function in dogs.
Insights
Canine NK cells express Ly49, a protein that likely binds to MHC-I, regulating immune responses. This finding is crucial for understanding dog cancer immunity and immunotherapy research.
Area of Science:
- Immunology
- Oncology
- Veterinary Medicine
Background:
- Natural killer (NK) cells are vital for cancer immunity.
- Dogs serve as important models for human immunotherapy research due to species-specific NK cell differences.
- The mechanism of self-recognition by canine NK cells remains unclear.
Purpose of the Study:
- To investigate the expression and function of Ly49 receptors in canine NK cells.
- To determine if canine Ly49 can interact with canine MHC class I (MHC-I).
Main Methods:
- In silico analysis of canine Ly49 gene and protein structure.
- Computational protein-protein docking of canine Ly49 with MHC-I.
- Bulk and single-cell RNA sequencing to assess Ly49/KLRA1 gene expression in NK cells.
- Analysis of Ly49 expression in resting and activated canine NK cells.
Main Results:
- Canine Ly49 protein structure shows similarity to the murine system.
- Computational docking predicts favorable binding of canine Ly49 to MHC-I.
- RNA sequencing confirms Ly49/KLRA1 expression in canine NK cells, increasing upon activation.
- Ly49 expression is predominantly found in NK cells.
Conclusions:
- Canine NK cells express functional Ly49 receptors capable of binding MHC-I.
- Ly49 likely plays a role in regulating canine NK cell activity.
- These findings advance canine immuno-oncology and translational research.


